Comera Life Sciences Holdings, Inc. Stock
Equities
CMRA
US20037C1080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 USD | -16.90% | -16.90% | -45.45% |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
Jan. 30 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
Financials (USD)
Sales 2021 | 320K | Sales 2022 | 633K | Capitalization | 24.41M |
---|---|---|---|---|---|
Net income 2021 | -5M | Net income 2022 | -18M | EV / Sales 2021 | 400 x |
Net cash position 2021 | 6.19M | Net Debt 2022 | 328K | EV / Sales 2022 | 39.1 x |
P/E ratio 2021 |
-7.26
x | P/E ratio 2022 |
-0.7
x | Employees | 13 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.53% |
1 day | -16.90% | ||
1 week | -16.90% | ||
Current month | -25.00% | ||
1 month | -14.29% | ||
3 months | -14.29% | ||
6 months | -90.42% | ||
Current year | -45.45% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Campbell
CEO | Chief Executive Officer | - | 22-04-12 |
Corporate Officer/Principal | - | 22-11-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stuart Randle
BRD | Director/Board Member | 64 | 22-05-18 |
James Sherblom
BRD | Director/Board Member | 68 | 20-12-31 |
Director/Board Member | 48 | 22-05-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.03 | -16.90% | 41,072 |
24-05-01 | 0.0361 | -9.75% | 58,916 |
24-04-30 | 0.04 | +10.80% | 2,250 |
24-04-26 | 0.0361 | 0.00% | 267 |
Delayed Quote OTC Markets, May 02, 2024 at 01:39 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-45.45% | 922K | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CMRA Stock